Nusayba Bagegni, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Aptitude Health
    Topic:
    Speaking Fees/Honoraria
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Onclive
    Topic:
    Speaking Fees/Honoraria
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    NCCN
    Topic:
    Speaking Fees/Honoraria
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Curio Science
    Topic:
    Speaking Fees/Honoraria
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Topic:
    Research Support/Grants
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sermonix Pharmaceuticals LLC
    Topic:
    Research Support/Grants
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    Research Support/Grants
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    Research Support/Grants
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Daiichi Sankyo
    Topic:
    Research Support/Grants
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Stemline Therapeutics
    Topic:
    Research Support/Grants
    Date added:
    02/21/2024
    Date updated:
    04/01/2025

Pages

Return to Best of ASCO 2025, Milwaukee